Can a monthly infusion tame stubborn IBD? new study tests faster dosing
NCT ID NCT04738942
First seen Jun 17, 2026 · Last updated Jun 17, 2026
Summary
This study tests whether giving vedolizumab every 4 weeks instead of every 8 weeks can help Japanese patients with moderate to severe ulcerative colitis or Crohn's disease whose symptoms returned during standard treatment. About 56 participants will receive the drug intravenously every 4 weeks, and doctors will check for symptom improvement after 12 weeks. The goal is to see if a more frequent dose can regain control of the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fukuoka University Chikushi Hospital
Chikushino-shi, Fukuoka, Japan
-
Hirosaki University Hospital
Hirosaki, Aomori, Japan
-
Hyogo College of Medicine Hospital
Nishinomiya, Hyōgo, Japan
-
Ieda Hospital
Toyota, Aichi-ken, Japan
-
Infusion Clinic.
Osaka, Japan
-
Institute of Science Tokyo Hospital
Bunkyo-ku, Tokyo, Japan
-
Jichi Medical University Hospital
Shimotsuke, Tochigi, Japan
-
Juntendo University Hospital
Bunkyo-ku, Tokyo, Japan
-
Keio University Hospital
Shinjuku-ku, Tokyo, Japan
-
Kitasato University Hospital
Sagamihara, Kanagawa, Japan
-
Kitasato University Kitasato Institute Hospital
Minato-ku, Tokyo, Japan
-
Kyorin University Hospital
Mitaka, Tokyo, Japan
-
Ofuna Chuo Hospital
Kamakura, Kanagawa, Japan
-
Osaka Metropolitan University Hospital
Osaka, Japan
-
Sapporo Kosei General Hospital
Sapporo, Hokkaido, Japan
-
Toho University Sakura Medical Center
Sakura, Chiba, Japan
-
Tohoku University Hospital
Sendai, Miyagi, Japan
-
Tokyo Yamate Medical Center
Shinjuku-ku, Tokyo, Japan
-
Tsujinaka Hospital
Kashiwa, Chiba, Japan
-
Yokohama City University Medical Center
Yokohama, Kanagawa, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.